Biological classification of cell lines derived from human extra-cranial neural tumors. 1988

C P Reynolds, and M M Tomayko, and L Donner, and L Helson, and R C Seeger, and T J Triche, and G M Brodeur
Department of Pediatrics, UCLA School of Medicine 90024.

UI MeSH Term Description Entries
D009423 Nervous System Neoplasms Benign and malignant neoplastic processes arising from or involving components of the central, peripheral, and autonomic nervous systems, cranial nerves, and meninges. Included in this category are primary and metastatic nervous system neoplasms. Neoplasms, Nervous System,Nervous System Tumors,Tumors of the Nervous System,Neoplasm, Nervous System,Nervous System Neoplasm,Nervous System Tumor,Tumor, Nervous System,Tumors, Nervous System
D009857 Oncogenes Genes whose gain-of-function alterations lead to NEOPLASTIC CELL TRANSFORMATION. They include, for example, genes for activators or stimulators of CELL PROLIFERATION such as growth factors, growth factor receptors, protein kinases, signal transducers, nuclear phosphoproteins, and transcription factors. A prefix of "v-" before oncogene symbols indicates oncogenes captured and transmitted by RETROVIRUSES; the prefix "c-" before the gene symbol of an oncogene indicates it is the cellular homolog (PROTO-ONCOGENES) of a v-oncogene. Transforming Genes,Oncogene,Transforming Gene,Gene, Transforming,Genes, Transforming
D002395 Catecholamines A general class of ortho-dihydroxyphenylalkylamines derived from TYROSINE. Catecholamine,Sympathin,Sympathins
D002460 Cell Line Established cell cultures that have the potential to propagate indefinitely. Cell Lines,Line, Cell,Lines, Cell
D002471 Cell Transformation, Neoplastic Cell changes manifested by escape from control mechanisms, increased growth potential, alterations in the cell surface, karyotypic abnormalities, morphological and biochemical deviations from the norm, and other attributes conferring the ability to invade, metastasize, and kill. Neoplastic Transformation, Cell,Neoplastic Cell Transformation,Transformation, Neoplastic Cell,Tumorigenic Transformation,Cell Neoplastic Transformation,Cell Neoplastic Transformations,Cell Transformations, Neoplastic,Neoplastic Cell Transformations,Neoplastic Transformations, Cell,Transformation, Cell Neoplastic,Transformation, Tumorigenic,Transformations, Cell Neoplastic,Transformations, Neoplastic Cell,Transformations, Tumorigenic,Tumorigenic Transformations
D005784 Gene Amplification A selective increase in the number of copies of a gene coding for a specific protein without a proportional increase in other genes. It occurs naturally via the excision of a copy of the repeating sequence from the chromosome and its extrachromosomal replication in a plasmid, or via the production of an RNA transcript of the entire repeating sequence of ribosomal RNA followed by the reverse transcription of the molecule to produce an additional copy of the original DNA sequence. Laboratory techniques have been introduced for inducing disproportional replication by unequal crossing over, uptake of DNA from lysed cells, or generation of extrachromosomal sequences from rolling circle replication. Amplification, Gene
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000951 Antigens, Neoplasm Proteins, glycoprotein, or lipoprotein moieties on surfaces of tumor cells that are usually identified by monoclonal antibodies. Many of these are of either embryonic or viral origin. Neoplasm Antigens,Tumor Antigen,Tumor Antigens,Antigen, Tumor,Antigens, Tumor

Related Publications

C P Reynolds, and M M Tomayko, and L Donner, and L Helson, and R C Seeger, and T J Triche, and G M Brodeur
May 1978, National Cancer Institute monograph,
C P Reynolds, and M M Tomayko, and L Donner, and L Helson, and R C Seeger, and T J Triche, and G M Brodeur
December 1990, Cell biology international reports,
C P Reynolds, and M M Tomayko, and L Donner, and L Helson, and R C Seeger, and T J Triche, and G M Brodeur
November 2001, Biological & pharmaceutical bulletin,
C P Reynolds, and M M Tomayko, and L Donner, and L Helson, and R C Seeger, and T J Triche, and G M Brodeur
January 2015, PloS one,
C P Reynolds, and M M Tomayko, and L Donner, and L Helson, and R C Seeger, and T J Triche, and G M Brodeur
April 1997, Brain pathology (Zurich, Switzerland),
C P Reynolds, and M M Tomayko, and L Donner, and L Helson, and R C Seeger, and T J Triche, and G M Brodeur
January 1985, Differentiation; research in biological diversity,
C P Reynolds, and M M Tomayko, and L Donner, and L Helson, and R C Seeger, and T J Triche, and G M Brodeur
February 1977, Journal of the National Cancer Institute,
C P Reynolds, and M M Tomayko, and L Donner, and L Helson, and R C Seeger, and T J Triche, and G M Brodeur
February 1975, International journal of cancer,
C P Reynolds, and M M Tomayko, and L Donner, and L Helson, and R C Seeger, and T J Triche, and G M Brodeur
October 1994, Cancer biochemistry biophysics,
C P Reynolds, and M M Tomayko, and L Donner, and L Helson, and R C Seeger, and T J Triche, and G M Brodeur
March 1977, Comptes rendus hebdomadaires des seances de l'Academie des sciences. Serie D: Sciences naturelles,
Copied contents to your clipboard!